The global cellular health screening market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period.
The market is witnessing growth due to factors such as increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases.
Download PDF Brochure Here : http://www.marketsandmarkets.com/pdfdownload.asp?id=227041930
Based on type, the market is segmented into single test panels and multi-test panels. The single test panels include telomere tests, oxidative stress tests, inflammation tests, and heavy metals tests. The multi-test panels segment is expected to grow at the highest CAGR during the forecast period. The preference for multi-test panels is increasing in the market as they provide results for multiple biomarkers in a single exam.
Based on sample type, the market is segmented into blood samples and other samples. The blood samples segment is projected to grow at the highest rate during the forecast period. The large share and high growth of this segment can primarily be attributed to the advantages of blood tests, greater preference for these tests among healthcare providers, and the concerns over the reliability of tests using other samples.
On the basis of sample collection site, the global cellular health screening market is segmented into at-home, in-office, and other sample collection sites. Among these, the at-home segment is expected to witness the highest growth during the forecast period. The growing adoption of home healthcare, increasing focus on the direct-to-consumer approach, and rising geriatric population are the major factors supporting this segment.
Among the four regional segments covered in the global cellular health screening market—North America, Europe, Asia, and the Rest of the World (RoW), Asia is expected to grow at the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the rising geriatric population, increasing burden of chronic diseases, expansion opportunities for market players, and growing number of initiatives to create awareness about healthy lifestyles and preventive healthcare in several Asian countries.
To ensure sustainability and growth in this highly competitive market, several established players focus on acquiring small players to strengthen their product offerings and expand their footprints across different geographies.